tradingkey.logo

Boehringer Ingelheim Provides Details Of Its FDA Approved Lung Cancer Treatment Hernexeos

ReutersAug 11, 2025 3:21 PM

-

  • BOEHRINGER INGELHEIM SAYS EACH 60-TABLET BOTTLE OF ITS APPROVED LUNG CANCER TREATMENT, HERNEXEOS, IS $21,667.01

  • BOEHRINGER INGELHEIM SAYS GOAL IS TO MAKE HERNEXEOS AVAILABLE TO PATIENTS AS SOON AS THEY RECEIVE PRESCRIPTION FROM THEIR HEALTHCARE PROVIDER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI